EIGR Eiger BioPharmaceuticals 8-K2021Eiger BioPharmaceuticals Updates on 2020 Progress and 2021 Plans
7 Jan 21
Files
SEC
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
EIGR 8-K Filings
- 7 Jan 21 Completion of Acquisition or Disposition of Assets
- 7 Jan 21 Eiger BioPharmaceuticals Updates on 2020 Progress and 2021 Plans
- 23 Nov 20 Entry into a Material Definitive Agreement
- 5 Nov 20 Eiger BioPharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
- 15 Oct 20 Other Events
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…